Artes Medical plans to restructure to cut costs
Friday April 18, 5:35 pm ET
Artes Medical plans to restructure but will still expand its ArteFill sales force
SAN DIEGO (AP) -- Medical technology company Artes Medical Inc. said Friday it is restructuring in an effort to reduce costs in line with expected revenue.
The company said the goal is to "re-align" its overall cost structure toward its prior 2008 revenue guidance of $13 million to $16 million. Meanwhile, it will continue expanding its sales force for the injectable implant ArteFill, which is used as a wrinkle treatment.
Artes said it believes it has enough cash, along with anticipated ArteFill sales, to fund the company through the first quarter of 2009.
Werbung
NewsFlash Hebt diese Aktie bald ab? Größtes Wolfram-Portfolio der USA vor der Neubewertung!? 
